Blogs | MedChemExpress

SH-BC-893 is an Orally Active Anti-neoplastic Sphingolipid Analog

SH-BC-893 is an orally active sphingolipid analog. It can be used for the research of cancer and metabolism-related diseases.
RLA-5331 is an Iron Activator Containing Anti-androgen

RLA-5331 is an iron activator containing anti-androgen. RLA-5331 is used for metastatic castrated tolerant prostate cancer (mCRPC) research.
Talotrexin, A RFC Specific Inhibitor, Targets DHFR to Inhibit Tumor Growth

Talotrexin (PT523), a classic antifolate, is an RFC (reduced folate carrier) specific inhibitor and selectively inhibits RFC transport.
ARN24139 is a TopoII Inhibitor with Promising Antiproliferative Activity

ARN24139 is a potential topoisomerase II (topoII) inhibitor that inhibits cancer cell proliferation and is useful in cancer research.
BPDA2 is a Highly Selective and Competitive SHP2 Inhibitor

BPDA2 is a competitive active site SHP2 inhibitor and suppresses SHP2-mediated signaling and breast cancer cell phenotypes.
Opnurasib (JDQ-443) is an Orally Active KRAS G12C Inhibitor

Opnurasib (JDQ-443) is a structurally novel, potent, and selective covalent oral inhibitor of KRAS G12C that exhibits antitumor activity.
Elacestrant (RAD1901) is an Orally Available Estrogen Receptor Degrader

Elacestrant (RAD1901) is an orally available selective estrogen receptor degrader. Elacestrant used for Breast cancer research.
Ferristatin (NSC306711) is a Potent Iron Transport Inhibitor and Promotes Transferrin Receptor Degradation

Ferristatin is a potent iron transport inhibitor and shows antiviral potency and anti-MTase (methyltransferase) activity.
Asunercept (APG101) is a Selective CD95L Inhibitor for Glioblastoma Research

Asunercept (APG101) is a soluble CD95-Fc fusion protein targeting CD95L.
J-113397 is a Potent and Selective ORL1 Receptor Antagonist

J-113397 is a potent and selective nonpeptidyl ORL1 receptor antagonist without any agonistic effects on other opioid receptors.

Name
Email *

	Sorry, but the email address you supplied was invalid.

Blogs (18)